EMAIL THIS PAGE TO A FRIEND

Talanta

Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers.


PMID 25159440

Abstract

An enantioselective high performance liquid chromatographic method with diode array detection (HPLC-DAD) was developed and validated for the determination of etodolac enantiomers in tablets and human plasma. Enantiomeric separation was achieved on a Kromasil Cellucoat chiral column (250 mm × 4.6mm i.d., 5 µm particle size) using a mobile phase consisting of hexane: isopropanol: triflouroacetic acid (90:10:0.1 v/v/v) at a flow rate of 1.0 mL min(-1). The chromatographic system enables the separation of the two enantiomers and the internal standard within a cycle time of 8 min. The resolution between the two enantiomers was 4.25 and the resolution between each enantiomer and the internal standard was more than 2.0. Detection was carried out at 274 nm, and the purity assessment was performed using a photodiode array detector. Solid phase extraction technique using C-18 cartridge was applied to extract the analytes from the plasma samples, and the percentage recovery was more than 95% for the lower quantification limit. The method has been validated with respect to selectivity, linearity, accuracy and precision, robustness, limit of detection and limit of quantification. The validation acceptance criteria were met in all cases. The linearity range for the determination of each enantiomer in human plasma was 0.4-30.0 µg mL(-1) and the limits of quantification of R-etodolac and S-etodolac were 0.20 and 0.19 µg mL(-1), respectively. The validated method was successfully applied to the determination of etodolac enantiomers in tablets and to a comparative pharmacokinetic study of the two enantiomers after the administration of 300 mg single oral dose etodolac racemate tablets to twelve healthy volunteers.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

K08971227 Kromasil® CelluCoat® Chiral HPLC Column, 3 μm particle size, L × I.D. 50 mm × 2.1 mm
K08971223 Kromasil® CelluCoat® Chiral HPLC Column, 3 μm particle size, L × I.D. 150 mm × 2.1 mm
K08971228 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 50 mm × 2.1 mm
K08971224 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 150 mm × 2.1 mm
K08670372 Kromasil® CelluCoat® Chiral HPLC Column, 3 μm particle size, L × I.D. 50 mm × 4.6 mm
K08670370 Kromasil® CelluCoat® Chiral HPLC Column, 3 μm particle size, L × I.D. 150 mm × 4.6 mm
K08670617 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 50 mm × 4.6 mm
K08670373 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 150 mm × 4.6 mm
K08670374 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 250 mm × 4.6 mm
K08670614 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 250 mm × 10  mm
K08670615 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 250 mm × 21.2 mm
K08670616 Kromasil® CelluCoat® Chiral HPLC Column, 5 μm particle size, L × I.D. 250 mm × 30 mm
K08670612 Kromasil® CelluCoat® Chiral HPLC Column, 10 μm particle size, L × I.D. 150 mm × 4.6 mm
K08670613 Kromasil® CelluCoat® Chiral HPLC Column, 10 μm particle size, L × I.D. 250 mm × 4.6 mm
K08670609 Kromasil® CelluCoat® Chiral HPLC Column, 10 μm particle size, L × I.D. 250 mm × 10 mm
K08670610 Kromasil® CelluCoat® Chiral HPLC Column, 10 μm particle size, L × I.D. 250 mm × 21.2 mm
K08670611 Kromasil® CelluCoat® Chiral HPLC Column, 10 μm particle size, L × I.D. 250 mm × 30 mm
K08670502 Kromasil® CelluCoat® Chiral Reversed Phase HPLC Column, 3 μm particle size, L × I.D. 50 mm × 4.6 mm
K08670503 Kromasil® CelluCoat® Chiral Reversed Phase HPLC Column, 3 μm particle size, L × I.D. 150 mm × 4.6  mm